The agreement has a term of 10-years and the two organisations will work in partnership to deliver advanced diagnostics services, through five new diagnostics centres across the UK. Under the terms of the agreement, which is built around a Managed Technology Service, Philips will deliver: state-of-the-art imaging equipment provision; management and technology utilisation reporting; continuous training; and a research and innovation program.
The impact of the COVID-19 pandemic has increased delays to cancer diagnosis and treatment in the United Kingdom. According to recent research, concerns around access to routine screenings, urgent referrals and treatments could lead to a potential 7,000 excess deaths – rising to a worst-case scenario of 35,000¹. Diagnostic centres such as Taunton will help support NHS capacity and expedite care of patients, improving efficiencies and patient experience. In addition to providing services to NHS patients, the centre will be available to private medical insurance and self-pay patients in the South West.
“For Philips, a successful partnership approach uses technology as an enabler to drive sustainable and improved clinical practices, patient outcomes and experience through innovation.” said Stephen McMillan, Solutions Lead for Philips in the UK and Ireland. “The current pandemic response has exacerbated the continuing challenges around how to ensure prompt access to healthcare as demand increases. Community Diagnostic Centres (CDC) and Community Diagnostic Training Centres (CDTC) have the ability to transform the current model of care delivery by providing access to ‘right first time’ diagnostic and treatment services closer to patient settings. Philips is proud to partner with Rutherford and looks forward to supporting the opening of their Taunton centre.”
“Our focus is to change the current healthcare paradigm from a reactive model which responds to disease, to one that is proactive and preventative with far reaching long-term benefits,” said Dr Steven Powell, Chief Diagnostic Officer of Rutherford Diagnostics. “We required a strategic partner who will complement our diagnostic service offering with technological innovation. Philips is closely aligned to our vision and can manage complexity while remaining flexible and is the right partner to support us on this journey.”
Philips and Rutherford Diagnostics will help expand access to diagnostic services for local patients in a cost-effective way that supports the best possible patient outcomes and experiences.
For more information on Philips Managed Services and Strategic Partnerships, please visit: http://philipsmanagedservices
Last accessed 13/07/20”